Abstract:Ganhua You, 1, 2 Xiangshu Long, 3, 4 Fang Song, 3, 4 Jing Huang, 3, 4 Maobo Tian, 3, 4 Yan Xiao, 3, 4 Shiyan Deng, 3, 4 Qiang Wu 3, 4 1 Guizhou University School of Medicine, Guiyang 550025, People's Republic of China; 2 Guizhou Institute for Food and Drug Control, Guiyang 550004, People's Republic of China; 3 Department of Cardiology, Guizhou Provincial People's Hospital, Guiyang 550002, People's Republic of China; 4 Department of Cardiology, People's Hospital of Guizhou University, Guiyang 550002, People's Republic of China Correspondence: Qiang Wu Department of Cardiology, Guizhou Provincial People's Hospital, 83 Zhongshan East Road, Guiyang, Guizhou, People's Republic of China Tel +86-0851-85937194 Fax +86-0851-85924943 Email wqgz0851@126.com Background: Metformin has been shown to inhibit the proliferation and migration of vascular wall cells. However, the mechanism through which metformin acts on atherosclerosis (AS) via the long non-coding RNA taurine up-regulated gene 1 (lncRNA TUG1 ) is still unknown. Thus, this research investigated the effect of metformin and lncRNA TUG1 on AS. Methods: First, qRT-PCR was used to detect the expression of lncRNA TUG1 in patients with coronary heart disease (CHD). Then, the correlation between metformin and TUG1 expression in vitro and their effects on proliferation, migration, and autophagy in vascular wall cells were examined. Furthermore, in vivo experiments were performed to verify the anti-AS effect of metformin and TUG1 to provide a new strategy for the prevention and treatment of AS. Results: qRT-PCR results suggested that lncRNA TUG1 expression was robustly upregulated in patients with CHD. In vitro experiments indicated that after metformin administration, the expression of lncRNA TUG1 decreased in a time-dependent manner. Metformin and TUG1 knockdown via small interfering RNA both inhibited proliferation and migration while promoted autophagy via the AMPK/mTOR pathway in vascular wall cells. In vivo experiments with a rat AS model further demonstrated that metformin and sh- TUG1 could inhibit the progression of AS. Conclusion: Taken together, our data demonstrate that metformin might function to prevent AS by activating the AMPK/mTOR pathway via lncRNA TUG1 . Keywords: metformin, taurine up-regulated gene 1, AMPK/mTOR, autophagy, atherosclerosis

Tiam-1, a GEF for Rac1, plays a critical role in metformin-mediated glucose uptake in C2C12 cells

Tiam1 Mediates Rac1 Activation and Contraction-Induced Glucose Uptake in Skeletal Muscle Cells.

Metformin is a Novel Suppressor for Transforming Growth Factor (Tgf)-Β1.

An EGFR/PI3K/AKT Axis Promotes Accumulation of the Rac1-GEF Tiam1 That is Critical in EGFR-driven Tumorigenesis.

The Tiam1 Guanine Nucleotide Exchange Factor is Auto-Inhibited by Its Pleckstrin Homology Coiled-Coil Extension Domain.

AMPK-mediated phosphorylation enhances the auto-inhibition of TBC1D17 to promote Rab5-dependent glucose uptake

Abstract 15090: AMP-Activated Protein Kinase Upregulates Sodium-Dependent Glucose Transporter SGLT1, Which Contributes to Cardiac Ischemia-Reperfusion Injury

A Tbc1d1 Ser231Ala -Knockin Mutation Partially Impairs AICAR- but Not Exercise-Induced Muscle Glucose Uptake in Mice

Metformin Effectively Treats Tsc1 Deletion-Caused Kidney Pathology by Upregulating AMPK Phosphorylation

Oct1 is A High-Capacity Thiamine Transporter That Regulates Hepatic Steatosis and is A Target of Metformin

A potential mechanism of metformin-mediated regulation of glucose homeostasis: Inhibition of Thioredoxin-interacting protein (Txnip) gene expression

GPRC6A is a Potential Therapeutic Target for Metformin Regulation of Glucose Homeostasis in Mice

AMPK/AS160 Mediates Tiliroside Derivatives-Stimulated GLUT4 Translocation in Muscle Cells

Metformin Attenuates Palmitic Acid-Induced Insulin Resistance In L6 Cells Through The Amp-Activated Protein Kinase/Sterol Regulatory Element-Binding Protein-1c Pathway

Metformin Activates the AMPK-mTOR Pathway by Modulating lncRNA TUG1 to Induce Autophagy and Inhibit Atherosclerosis

AMPK-induced novel phosphorylation of RUNX1 inhibits STAT3 activation and overcome imatinib resistance in chronic myelogenous leukemia (CML) subjects

Metformin inhibits mitochondrial dysfunction and apoptosis in cardiomyocytes induced by high glucose via upregulating AMPK activity

Genomic Characterization of Metformin Hepatic Response

Metformin and phenformin activate AMP-activated protein kinase in the heart by increasing cytosolic AMP concentration

TGF-β1 Signaling Impairs Metformin Action on Glycemic Control